Unique Formosan MushroomAntrodia camphorataDifferentially Inhibits Androgen-Responsive LNCaP and -Independent PC-3 Prostate Cancer Cells
Authors:
- 4 May 2007
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 57 (1) , 111-121
Abstract
Antrodia camphorata (AC), a precious and unique folkloric medicinal mushroom enriched in polyphenolics, isoflavonoids, triterpenoids, and polysaccharides, has been diversely used in Formosa (Taiwan) since the 18th century. In this study, prostate cancer (PCa) cell lines PC-3 (androgen independent) and LNCaP (androgen responsive) were treated with AC crude extract (ACCE) at 50–200 μ g/mL, respectively, for 48 h. At the minimum effective dose 150 μ g/mL, LNCaP showed a G 1 /S phase arrest with significant apoptosis. Such dose-dependent behavior of LNCaP cells in response to ACCE was confirmed to proceed as Akt → p53→ p21→ CDK4/cyclin D1→ G 1 /S-phase arrest→ apoptosis, which involved inhibiting cyclin D1 activity and preventing pRb phosphorylation. In contrast, being without p53, PC-3 cells showed a G 2 /M-phase arrest mediated through pathway p21→ cyclin B1/Cdc2→ G 2 /M-phase arrest, however, with limited degree of apoptosis, implicating that ACCE is able to differentially inhibit the growth of different PCa cells by modulating different cell cycle signaling pathways. We conclude that this unique Formosan mushroom, A. camphorata, due to its nontoxicity, might be used as a good adjuvant anticancer therapy for prostate cancers despite its androgen-responsive behaviors, which has long been a serious drawback often encountered clinically in hormonal refractory cases treated by antihormonal therapies and chemotherapeutics.Keywords
This publication has 45 references indexed in Scilit:
- The androgen receptor and signal‐transduction pathways in hormone‐refractory prostate cancer. Part 2: androgen‐receptor cofactors and bypass pathwaysBJU International, 2005
- Complementary and Alternative Therapies for CancerThe Oncologist, 2004
- Modulation of phosphatidylinositol‐3‐kinase/protein kinase B‐ and mitogen‐activated protein kinase‐pathways by tea polyphenols in human prostate cancer cellsJournal of Cellular Biochemistry, 2003
- Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. SeedsPhytotherapy Research, 2003
- Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival PathwayJournal of Biological Chemistry, 2003
- p53‐independent Induction of p21 (WAF1/CIP1), Reduction of Cyclin B1 and G2/M Arrest by the Isoflavone Genistein in Human Prostate Carcinoma CellsJapanese Journal of Cancer Research, 2000
- Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expressionOncogene, 1998
- Transcriptional control of the cell cycleCurrent Opinion in Cell Biology, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993